Thursday November 23, 2017

Caripill: Bengaluru-based lab comes with tab to cure dengue

10
79567
photo credit: www.euvaccine.eu

By NewsGram Staff-writer

New Delhi: Amid dengue deaths that has captured the imagination of the nation, for all the wrong reasons, a Bengaluru-based laboratory claims to have achieved a breakthrough in creating a tablet for the disease which aims to increase platelet count.

Caripill Tablet is used for Dengue fever, Oxidative stress, Wound healing, Thrombocytopenia and other conditions. Caripill Tablet may also be used for purposes not listed in this medication guide.

Caripill Tablet contains Carica Papaya as an active ingredient.

Caripill Tablet works by modifying the adsorption and penetration of the virion; lowering lipid peroxidation level; stimulating the rate of increase in platelet count.

Detailed information related to Caripill Tablet’s uses, composition, dosage, side effects and reviews is listed below.

photo credit: fellowplanet.blogspot.com
photo credit: fellowplanet.blogspot.com

A botanical pill with the name of ‘Caripill’ was launched by Micro Labs Ltd, which increases the platelet count in dengue patients. Scientific and regulatory authorities have approved the drug which is made from the extract of carica papaya leaf. The clinical trials showed no side-effects of the Caripill tablets.

Positive results were shown by the drug with an effective decrease in haemorrhage condition, claimed the lab. In addition, patients did not require the blood transfusion process which is almost mandatory for dengue patients as they require platelets from donor’s blood.

Caripill is considered, with scientific support, to increase the platelet count in dengue patients. Since the drug is considered to be effective in treating dengue, lab is sure that it can also be helpful in treating diseases like leukaemia where chemotherapy is required which leads to loss of platelets.

Caripill is now available at all major pharmacies across India costing Rs 25 per tablet with a dosage of one tab (1100 mg) three times a day, for five days.

Delhi has witnessed a sudden increase in dengue cases this year as compared to past five years which has claimed 11 lives so far. World Health Organisation stated that dengue, globally, is becoming a serious health problem.

10 COMMENTS

  1. I am NOT HAPPY.There is no relief.There is NO increament of
    platelets after using the medicine.Before the treatment ,my Platelets count was
    1 Lakh.Then after looking at the press release of Micro labs,I started using
    Caripill for 7 and half days ,2 caps per day and one on the eighth day on
    Doctor’s advice.After the treatment is over,I got tested my blood sample and it
    is only 1 Lakh.To verify the doubt,I got tested the blood sample and it is
    again 1L Lakh only.So now,shoild I ask the Druggists to ‘revisit’ their claim?
    or they will again thoroughly ‘test’ the medicine and come to the market??

    Dr.V S SARMA,

    Retired Scientist,

    Hyderabad
    Mobile : 09246534877

    • What if it stabilised your platelet count for those 7 and half days. In other words, it might have compensated further loss.

      • we all are talking about cures and symptoms, but is there anyone doing anything about the precautions?. People are ending up dead…there ain’t no point talking to the labs manufacturing em, cuz to be frank its their business..somewhere or the other we do have to reply on Ayurveda for the cure, and if we Indians cant do it than how can we reply on foreign countries??

        • It’s not a cure if it targets only platelet count. Does this remove the virus?? Papaya leaf juice +a lot of watrr helps. If you have not seen a doctor, go see one asap. You also need to address your diet if the intermittent fever has gone and your platelets have not receeded…

    • SIr , actually a point here , best i know in case of dengue (as couple of my friends are found positive in dengue ) once the platelets count reached below 1.5 Lakh . It continues to decrease untill some external remedy or death . How come in your case , it didn’t dipped below 1 Lakh and that surprisingly for 7 and half days ?
      In dengue it’s not possible without extra remedy !!
      either the capsules worked or you might took any other extra remedies . In any case please let me know how you maintained that 1 lakh for 7 and half days ? as in dengue that 1 lakh count reaches to below 35 thousand in just 12-14 hours untill/unless you take doctor assistance .

      • Drug name caripill tab you should take thrice in day for five days, after taking the medicine it will rise the platlate count within 48 Hour. Keep try, freely available in main counter cost were RS 375 only by MICRO LABS it is tasted in dengu indused thrombocytopenia.

  2. well anyone who is well informed would know that the platelet count can be increased with the juice of papaya leaf.. but then if just a tablet is doing the work,, its good

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Next Story

Delhi records 3,829 cases of dengue, 502 of chikungunya till date

The year 2015 had reported the highest number of cases of dengue in the city, with the figure standing at 15,867 with 60 deaths.

0
25
cases of dengue
Dengue and Chikungunya are viral diseases transmitted to humans via infected mosquitoes. Pixabay

New Delhi, November 7, 2017 :  Delhi has so far recorded 3,829 cases of dengue and 502 cases of chikungunya, according to civic agencies on Monday.

While the national capital has witnessed a total of four dengue-related deaths till now, no deaths have been reported due to chikungunya.

ALSO READ You May Soon Be Able to Prevent Chikungunya With Vaccines! IIT-Roorkee Researchers Discover Drug to Fight the Disease

The year 2015 reported the highest number of cases of dengue in the city, with the figure standing at 15,867 with 60 deaths.

As for chikungunya, 2016 saw 7,117 cases — the highest in the last five years.

Civic agencies said that areas under the South Delhi Municipal Corporation reported the maximum cases of chikungunya and dengue this year.

ALSO READ What preventive steps have the city Government taken to control Dengue and Chikungunya, asks the Delhi High Court

Delhi has also reported a total of 552 malaria cases with no deaths so far. The figure is the second-highest after 2012 when the cases had soared to 822. (IANS)

Next Story

You May Soon Be Able to Prevent Chikungunya With Vaccines! IIT-Roorkee Researchers Discover Drug to Fight the Disease

At present, there are no immunizations or anti-viral medications available to cure Chikungunya, and the treatment is focused on mitigating the side effects related with the disease

0
59
cases of dengue
Dengue and Chikungunya are viral diseases transmitted to humans via infected mosquitoes. Pixabay

Roorkee, October 9, 2017 : Dengue and Chikungunya are known to strike fear in the country every year, so much so that the health graph of the city registers a steep rise in these cases. Both of the water-borne diseases, characterized by high fever and pain in the joints, take a toll on our lives. So far, there is no vaccine to immunize people against the spread of the Dengue and Chikungunya virus. However, researchers at IIT-Roorkee have now discovered that a commonly-utilized de-worming drug can be efficiently used for treatments against Chikungunya.

According to a report by PTI, Shailly Tomar, lead researcher and a professor at Indian Institute of Technology (IIT) Roorkee in Uttarakhand was quoted as saying, “Our research has shown that piperazine, a drug existing in the market, is successful in curbing the spread and replication of the Chikungunya virus in a lab setting.”

The drug, Piperazine, is usually used in de-worming treatments against round-words and pinworms. Using their expertise in virology and structure biology, experts have now discovered the anti-viral capabilities of the drug that can potentially prompt new therapies against the fatal, mosquito borne disease.

The researchers are currently testing the molecule on animals, and will consequently take it to clinical trials.

ALSO READ What preventive steps have the city Government taken to control Dengue and Chikungunya, asks the Delhi High Court

The molecular details uncovered in the study, which has been published in the journal Antiviral Research, will be additionally used to plan piperazine-derivative medications that are more compelling to fight against the Chikungunya virus.

Using X-ray crystallographic technique, in combination with computational science and fluorescence strategies, the researchers discovered that piperazine binds itself with the hydrophobic (water-hating) pocket of capsid protein present in the Chikungunya virus, which can reduce the spread of the virus.

“This pocket is key to the replication of the virus and its spread inside a host. Inhibiting the pocket prevents budding and spread of the virus and can help in treating the virus effectively using existing drugs,” Tomar said.

Chikungunya has become a major public health concern, with an increasing number of people being plagued by the disease every year.

 At present, there are no immunizations or anti-viral medications available to cure Chikungunya, and the treatment is focused on mitigating the side effects related with the disease. 

Developing a new anti-viral drug molecule can take up to 10 years. To tend to the disease on an immediate basis, Professor Tomar added, “We are looking at repositioning existing, approved drugs and testing these to see if they might inhibit or kill pathogenic viruses.”

 

 

Next Story

Central government hospitals in India to reserve beds for Dengue, Chikungunya

At least 14 people have died in the national capital since the outbreak of the vector-borne disease in last a few days

3
131
Mosquito. Wikimedia

NEW DELHI, Sept 16, 2016: The central government has agreed to reserve 10 percent of the beds in its hospitals for treatment of dengue and chikungunya patients, according to Delhi Health Minister Satyendar Jain.

Jain’s remarks came after meeting Union Health Minister J.P. Nadda at his office here on Friday.

“We had requested Mr Nadda to reserve at least 10 percent beds (1,000 beds) in the central government-run hospitals, like All India Institute of Medical Sciences (AIIMS), Safdarjung Hospital, Ram Manohar Lohia Hospital, etc., for treatment of dengue and chikungunya cases, to which he (Nadda) agreed,” Jain told reporters after the meeting.

Earlier, Jain had sought an appointment with Nadda and also written him a letter requesting the Union Minister to convene a meeting of the health ministers of neighbouring states.

Follow NewsGram on Facebook

AIIMS. Wikimedia
AIIMS. Wikimedia

He urged Nadda to ask health ministers of neighbouring states like Uttar Pradesh and Haryana to set up fever clinics in order to reduce excessive patient inflow in the hospitals of Delhi.

“The government should also advertise about these fever clinics, so that people could know about it,” he added.

Asked whether Delhi will take patients from other states, Jain said, “We are not denying treatment to anybody coming to Delhi For treatment.”

Follow NewsGram on Twitter

He also said that in Delhi government hospitals more than 1,500 beds are available, and there is no need for panic. “We are working day and night,” he added.

At least 14 people have died in the national capital since the outbreak of the vector-borne disease in last a few days. (IANS)